Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Moderna, Inc.    MRNA

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Swiss to get Moderna vaccine in tranches until mid-year - Blick

01/17/2021 | 03:55am EST

ZURICH, Jan 17 (Reuters) - Moderna will deliver 7.5 million doses of COVID-19 vaccine to Switzerland in batches in the months ahead, putting the country among the world leaders in inoculating its population, the head of Moderna's European business said.

"We are working at full speed to steadily expand our production capacities. If everything goes as planned, just under half the population could be treated with our vaccine by the summer," Dan Staner told the SonntagsBlick newspaper in an interview.

Staner said Switzerland would not get privileged treatment because it was the first country to chose Moderna as a supplier.

"Every country deserves equal treatment. We refrain from stockpiling vaccines and delivering them only when a country orders them. Every dose that is produced is delivered immediately, according to the contract," he said.

"People are suffering in the same way all over the world. In times like these no one deserves special treatment."

Swiss regulators have approved vaccines from Moderna and from Pfizer with partner BioNTech. They are still reviewing a vaccine from AstraZeneca.

Switzerland, with a population of 8.6 million, has ordered 15 million vaccine doses in total after setting aside 400 million Swiss francs ($449 million) for shots.

($1 = 0.8907 Swiss francs) (Reporting by Michael Shields; Editing by Toby Chopra)


© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC -0.22% 7120 Delayed Quote.-1.75%
BIONTECH SE 1.69% 114.05 Delayed Quote.40.58%
MODERNA, INC. -3.73% 144.81 Delayed Quote.52.55%
PFIZER INC. -0.02% 33.905 Delayed Quote.-6.93%
All news about MODERNA, INC.
03:06pPFIZER : For Israel's allies, road to vaccines runs through Jerusalem
AQ
02:58pJOHNSON & JOHNSON : COVID-19 Vaccine Candidate Endorsed by FDA Staff Ahead of Ke..
MT
02:44pJOHNSON & JOHNSON : J&J's Covid-19 Vaccine Is Safe and Effective, FDA Says--Upda..
DJ
12:45pFDA says single-dose shot from J&J prevents severe COVID
AQ
11:28aUS takes 1st step toward approving single-dose Covid-19 vaccine
AQ
11:23aJOHNSON & JOHNSON : FDA Says Johnson & Johnson's Covid Vaccine Has a 'Favorable ..
DJ
10:56aASTRAZENECA : Johnson & Johnson's one-dose vaccine closes in on U.S. approval
RE
10:32aFDA says J&J 1-dose shot prevents COVID; final decision soon
AQ
09:23aFDA says Johnson & Johnson COVID-19 vaccine safe, has few side effects
AQ
08:53aJOHNSON & JOHNSON : FDA Says Johnson & Johnson's Covid Vaccine Has a 'Favorable ..
DJ
More news
Financials (USD)
Sales 2020 502 M - -
Net income 2020 -582 M - -
Net cash 2020 2 597 M - -
P/E ratio 2020 -120x
Yield 2020 -
Capitalization 59 424 M 59 424 M -
EV / Sales 2020 113x
EV / Sales 2021 4,52x
Nbr of Employees 1 100
Free-Float 90,0%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 155,50 $
Last Close Price 150,17 $
Spread / Highest target 43,2%
Spread / Average Target 3,55%
Spread / Lowest Target -46,7%
EPS Revisions
Managers and Directors
NameTitle
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capitalization (M$)
MODERNA, INC.52.55%59 424
LONZA GROUP AG2.88%48 232
IQVIA HOLDINGS INC.6.63%36 544
CELLTRION, INC.-21.45%36 331
SEAGEN INC.-10.03%28 448
HANGZHOU TIGERMED CONSULTING CO.,LTD-5.39%21 198